longipinene: isolated from Santolina viscosa; structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Santolina | genus | [no description available] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 12311396 |
CHEBI ID | 62752 |
CHEBI ID | 62753 |
MeSH ID | M0366275 |
Synonym |
---|
(1r,2s,7r,8r)-2,6,6,9-tetramethyltricyclo[5.4.0.0(2,8)]undec-9-ene |
3,3,7,9-tetramethyltricyclo(5.4.0.0(2,8))undec-9-ene |
CHEBI:62752 |
CHEBI:62753 , |
tricyclo(5.4.0.0(2,8))undec-9-ene, 3,3,7,9-tetramethyl- |
unii-104an9v5q1 |
104an9v5q1 , |
longipinene |
tricyclo(5.4.0.02,8)undec-9-ene, 2,6,6,9-tetramethyl-, (1r,2s,7r,8r)- |
(+)-.alpha.-longipinene |
Q27132143 |
DTXSID30975297 |
(1r,2s,7r,8r)-2,6,6,9-tetramethyltricyclo[5.4.0.02,8]undec-9-ene |
(1r,2s,7r,8r)-2,6,6,9-tetramethyltricyclo[5.4.0.0?,?]undec-9-ene |
2,6,6,9-tetramethyltricyclo(5.4.0.0(2,8))undec-9-ene |
Role | Description |
---|---|
metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
alpha-longipinene | A bridged compound and sesquiterpene that is tricyclo[5.4.0.0(2,8)]undecane that is substituted by methyl groups at the 2, 6, 6, and 9 positions and has a double bond between positions 9 and 10. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 4 (33.33) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |